Moreover, the long-term oral administration of MLE had a potential treatment effect on hyperglycemia, hyperinsulinemia, and metabolic profile alteration in the T2DM rat model by inhibiting DPP-IV and activating GLP-1 secretion. This evidence concerns the gene DPP4 and Hyperglycemia.